Supportive Care in Cancer

, Volume 26, Issue 5, pp 1543–1552 | Cite as

Oral curcumin for radiation dermatitis: a URCC NCORP study of 686 breast cancer patients

  • Julie Ryan Wolf
  • Charles E. Heckler
  • Joseph J. Guido
  • Anita R. Peoples
  • Jennifer S. Gewandter
  • Marilyn Ling
  • Vincent P. Vinciguerra
  • Thomas Anderson
  • Lisa Evans
  • James Wade
  • Alice P. Pentland
  • Gary R. Morrow
Original Article

Abstract

Purpose

Despite advances in medical technology, radiation dermatitis occurs in 95% of patients receiving radiation therapy (RT) for cancer. Currently, there is no standard and effective treatment for the prevention or control of radiation dermatitis. The goal of the study was to determine the efficacy of oral curcumin, one of the biologically active components in turmeric, at reducing radiation dermatitis severity (RDS) at the end of RT, using the RDS scale, compared to placebo.

Methods

This was a multisite, randomized, double-blinded, placebo-controlled trial of 686 breast cancer patients. Patients took four 500-mg capsules of placebo or curcumin three times daily throughout their prescribed course of RT until 1 week post-RT.

Results

A total of 686 patients were included in the final analyses (87.5% white females, mean age = 58). Linear mixed-model analyses demonstrated that curcumin did not reduce radiation dermatitis severity at the end of RT compared to placebo (B (95% CI) = 0.044 (− 0.101, 0.188), p = 0.552). Fewer curcumin patients with RDS > 3.0 suggested a trend toward reduced severity (7.4 vs. 12.9%, p = 0.082). Patient-reported changes in pain, symptoms, and quality of life were not statistically significant between arms.

Conclusions

Oral curcumin did not significantly reduce radiation dermatitis severity compared to placebo. The skin rating variation and broad eligibility criteria could not account for the undetectable therapeutic effect. An objective measure for radiation dermatitis severity and further exploration for an effective treatment for radiation dermatitis is warranted.

Keywords

Radiation therapy Dermatitis Curcumin Cancer Skin 

Notes

Acknowledgements

This study was supported by the FDA IND 75,444, the National Institutes of Health PHS grant R25CA102618 (Cancer Control research), and UG1CA189961 (NCORP).

Compliance with ethical standards

Conflict of interest

None of the authors have any conflicts of interest to disclose. I (JRW) have full control of all primary data and agree to allow the journal to review the data if requested.

References

  1. 1.
    Shah C, Kundu N, Arthur D, Vicini F (2013) Radiation therapy following postmastectomy reconstruction: a systematic review. Ann Surg Oncol 20:1313–1322CrossRefPubMedGoogle Scholar
  2. 2.
    Archambeau JO, Pezner R, Wasserman T (1995) Pathophysiology of irradiated skin and breast. Int J Radiat Oncol Biol Phys 31:1171–1185CrossRefPubMedGoogle Scholar
  3. 3.
    Dayes IS, Whelan TJ, Julian JA, Kuettel MR, Regmi D, Okawara GS, Patel M, Reiter HI, Dubois S (2006) Cross-border referral for early breast cancer: an analysis of radiation fractionation patterns. Curr Oncol 13:124–129PubMedPubMedCentralGoogle Scholar
  4. 4.
    Fujii O, Hiratsuka J, Nagase N, Tokiya R, Yoden E, Sonoo H, Murashima N, Iha S, Imajyo Y (2008) Whole-breast radiotherapy with shorter fractionation schedules following breast-conserving surgery: short-term morbidity and preliminary outcomes. Breast Cancer 15:86–92CrossRefPubMedGoogle Scholar
  5. 5.
    Di Franco R, Calvanese M, Murino P, Manzo R, Guida C, Di Gennaro D, Anania C, Ravo V (2012) Skin toxicity from external beam radiation therapy in breast cancer patients: protective effects of resveratrol, lycopene, vitamin C and anthocianin (Ixor(R)). Radiat Oncol 7:12CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Bray FN, Simmons BJ, Wolfson AH, Nouri K (2016) Acute and chronic cutaneous reactions to ionizing radiation therapy. Dermatol Ther 6:185–206CrossRefGoogle Scholar
  7. 7.
    Hymes SR, Strom EA, Fife C (2006) Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006. J Am Acad Dermatol 54:28–46CrossRefPubMedGoogle Scholar
  8. 8.
    Ryan JL (2012) Ionizing radiation: the good, the bad, and the ugly. J Investig Dermatol 132:985–993CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Hickok JT, Morrow GR, Roscoe JA, Mustian K, Okunieff P (2005) Occurrence, severity, and longitudinal course of twelve common symptoms in 1129 consecutive patients during radiotherapy for cancer. J Pain Symptom Manag 30:433–442CrossRefGoogle Scholar
  10. 10.
    Robertson C, Robertson AG, Hendry JH, Roberts SA, Slevin NJ, Duncan WB, MacDougall RH, Kerr GR, O'Sullivan B, Keane TJ (1998) Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers. Int J Radiat Oncol Biol Phys 40:319–329CrossRefPubMedGoogle Scholar
  11. 11.
    Gupta SC, Patchva S, Aggarwal BB (2013) Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J 15:195–218CrossRefPubMedGoogle Scholar
  12. 12.
    Prasad S, Aggarwal BB (2011) Turmeric, the golden spice: from traditional medicine to modern medicine. In: Benzie IFF W-GS (ed) Herbal medicine: biomolecular and clinical aspects. CRC Press/Taylor & FrancisGoogle Scholar
  13. 13.
    Gopinath D, Ahmed MR, Gomathi K, Chitra K, Sehgal PK, Jayakumar R (2004) Dermal wound healing processes with curcumin incorporated collagen films. Biomaterials 25:1911–1917CrossRefPubMedGoogle Scholar
  14. 14.
    Jagetia GC, Rajanikant GK (2005) Curcumin treatment enhances the repair and regeneration of wounds in mice exposed to hemibody gamma-irradiation. Plast Reconstr Surg 115:515–528CrossRefPubMedGoogle Scholar
  15. 15.
    Phan TT, See P, Lee ST, Chan SY (2001) Protective effects of curcumin against oxidative damage on skin cells in vitro: its implication for wound healing. J Trauma 51:927–931CrossRefPubMedGoogle Scholar
  16. 16.
    Vaughn AR, Branum A, Sivamani RK (2016) Effects of Turmeric (Curcuma longa) on Skin Health: A Systematic review of the clinical evidence. Phytother Res: PTR 30:1243–1264CrossRefPubMedGoogle Scholar
  17. 17.
    Gallardo M, Calaf GM (2016) Curcumin and epithelial-mesenchymal transition in breast cancer cells transformed by low doses of radiation and estrogen. Int J Oncol 48:2534–2542CrossRefPubMedGoogle Scholar
  18. 18.
    Jagetia GC, Rajanikant GK (2015) Curcumin Stimulates the Antioxidant Mechanisms in Mouse Skin Exposed to Fractionated gamma-Irradiation. Antioxidants 4:25–41CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Jayakumar S, Patwardhan RS, Pal D, Sharma D, Sandur SK (2016) Dimethoxycurcumin, a metabolically stable analogue of curcumin enhances the radiosensitivity of cancer cells: possible involvement of ROS and thioredoxin reductase. Biochem Biophys Res Commun 478:446–454CrossRefPubMedGoogle Scholar
  20. 20.
    Kumar B, Yadav A, Hideg K, Kuppusamy P, Teknos TN, Kumar P (2014) A novel curcumin analog (H-4073) enhances the therapeutic efficacy of cisplatin treatment in head and neck cancer. PLoS One 9:e93208CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Heger M, van Golen RF, Broekgaarden M, Michel MC (2014) The molecular basis for the pharmacokinetics and pharmacodynamics of curcumin and its metabolites in relation to cancer. Pharmacol Rev 66:222–307CrossRefPubMedGoogle Scholar
  22. 22.
    Okunieff P, Xu J, Hu D, Liu W, Zhang L, Morrow G, Pentland A, Ryan JL, Ding I (2006) Curcumin protects against radiation-induced acute and chronic cutaneous toxicity in mice and decreases mRNA expression of inflammatory and fibrogenic cytokines. Int J Radiat Oncol Biol Phys 65:890–898CrossRefPubMedGoogle Scholar
  23. 23.
    Ryan JL, Heckler CE, Ling M, Katz A, Williams JP, Pentland AP, Morrow GR (2013) Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients. Radiat Res 180:34–43CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ (1997) Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 133:1433–1440CrossRefPubMedGoogle Scholar
  25. 25.
    Kenward MG, Roger JH (1997) Small sample inference for fixed effects from restricted maximum likelihood. Biometrics 53:983–997CrossRefPubMedGoogle Scholar
  26. 26.
    Little RJA, Rubin DB (2002) Statistical analysis with missing data. Wiley, Hoboken, NJCrossRefGoogle Scholar
  27. 27.
    Ferreira EB, Vasques CI, Gadia R, Chan RJ, Guerra EN, Mezzomo LA, De Luca Canto G, Dos Reis PE (2017) Topical interventions to prevent acute radiation dermatitis in head and neck cancer patients: a systematic review. Supportive care in cancer: official journal of the multinational association of. Support Care Cancer 25:1001–1011CrossRefPubMedGoogle Scholar
  28. 28.
    Liguori V, Guillemin C, Pesce GF, Mirimanoff RO, Bernier J (1997) Double-blind, randomized clinical study comparing hyaluronic acid cream to placebo in patients treated with radiotherapy radiotherapy and oncology: journal of the European Society for Therapeutic. Radiol Oncol 42:155–161CrossRefGoogle Scholar
  29. 29.
    Schmuth M, Wimmer MA, Hofer S, Sztankay A, Weinlich G, Linder DM, Elias PM, Fritsch PO, Fritsch E (2002) Topical corticosteroid therapy for acute radiation dermatitis: a prospective, randomized, double-blind study. Br J Dermatol 146:983–991CrossRefPubMedGoogle Scholar
  30. 30.
    Shaw SZ, Nien HH, CJ W, Lui LT, JF S, Lang CH (2015) 3M Cavilon no-sting barrier film or topical corticosteroid (mometasone furoate) for protection against radiation dermatitis: a clinical trial. J Formos Med Assoc = Taiwan yi zhi 114:407–414CrossRefPubMedGoogle Scholar
  31. 31.
    Ulff E, Maroti M, Serup J, Nilsson M, Falkmer U (2016) Prophylactic treatment with a potent corticosteroid cream ameliorates radiodermatitis, independent of radiation schedule: A randomized double blinded study. Radiother Oncol: J Eur Soc Therap Radiol OncolGoogle Scholar
  32. 32.
    Bhagavathula N, Warner RL, DaSilva M, McClintock SD, Barron A, Aslam MN, Johnson KJ, Varani J (2009) A combination of curcumin and ginger extract improves abrasion wound healing in corticosteroid-impaired hairless rat skin. Wound repair and regeneration: official publication of the wound healing society [and] the European tissue repair. Society 17:360–366Google Scholar
  33. 33.
    Fray TR, Watson AL, Croft JM, Baker CD, Bailey J, Sirel N, Tobias A, Markwell PJ (2004) A combination of aloe vera, curcumin, vitamin C, and taurine increases canine fibroblast migration and decreases tritiated water diffusion across canine keratinocytes in vitro. J Nutr 134:2117S–2119SCrossRefPubMedGoogle Scholar
  34. 34.
    Delfino S, Brunetti B, Toto V, Persichetti P (2008) Burn after breast reconstruction. Burns: J Int Soc Burn Injuries 34:873–877CrossRefGoogle Scholar
  35. 35.
    Sekiguchi K, Kawamori J, Yamauchi H (2017) Breast reconstruction and postmastectomy radiotherapy: complications by type and timing and other problems in radiation oncology. Breast CancerGoogle Scholar
  36. 36.
    Gonzalez Sanchis A, Brualla Gonzalez L, Sanchez Carazo JL, Gordo Partearroyo JC, Esteve Martinez A, Vicedo Gonzalez A, Lopez Torrecilla JL (2017) Evaluation of acute skin toxicity in breast radiotherapy with a new quantitative approach radiotherapy and oncology: journal of the European Society for Therapeutic. Radiol Oncol 122:54–59CrossRefGoogle Scholar
  37. 37.
    Esteva A, Kuprel B, Novoa RA, Ko J, Swetter SM, Blau HM, Thrun S (2017) Dermatologist-level classification of skin cancer with deep neural networks. Nature 542:115–118CrossRefPubMedGoogle Scholar
  38. 38.
    Zenda S, Ota Y, Tachibana H, Ogawa H, Ishii S, Hashiguchi C, Akimoto T, Ohe Y, Uchitomi Y (2016) A prospective picture collection study for a grading atlas of radiation dermatitis for clinical trials in head-and-neck cancer patients. J Radiat Res 57:301–306CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Baker M (2017) Deceptive curcumin offers cautionary tale for chemists. Nature 541:144–145CrossRefPubMedGoogle Scholar
  40. 40.
    Heger M (2017) Drug screening: Don't discount all curcumin trial data. Nature 543:40CrossRefPubMedGoogle Scholar
  41. 41.
    Alibeiki F, Jafari N, Karimi M, Peeri Dogaheh H (2017) Potent anti-cancer effects of less polar curcumin analogues on gastric adenocarcinoma and esophageal squamous cell carcinoma cells. Sci Rep 7:2559CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Hussain Z, Thu HE, Ng SF, Khan S, Katas H (2017) Nanoencapsulation, an efficient and promising approach to maximize wound healing efficacy of curcumin: a review of new trends and state-of-the-art colloids and surfaces B. Biointerfaces 150:223–241CrossRefPubMedGoogle Scholar
  43. 43.
    Jager R, Lowery RP, Calvanese AV, Joy JM, Purpura M, Wilson JM (2014) Comparative absorption of curcumin formulations. Nutr J 13:11CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Li X, Ye X, Qi J, Fan R, Gao X, Wu Y, Zhou L, Tong A, Guo G (2016) EGF and curcumin co-encapsulated nanoparticle/hydrogel system as potent skin regeneration agent. Int J Nanomedicine 11:3993–4009CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Palatty PL, Azmidah A, Rao S, Jayachander D, Thilakchand KR, Rai MP, Haniadka R, Simon P, Ravi R, Jimmy R, D'Souza PF, Fayad R, Baliga MS (2014) Topical application of a sandal wood oil and turmeric based cream prevents radiodermatitis in head and neck cancer patients undergoing external beam radiotherapy: a pilot study. Br J Radiol 87:20130490CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2017

Authors and Affiliations

  • Julie Ryan Wolf
    • 1
    • 2
    • 3
  • Charles E. Heckler
    • 3
    • 4
  • Joseph J. Guido
    • 3
    • 4
  • Anita R. Peoples
    • 3
  • Jennifer S. Gewandter
    • 5
  • Marilyn Ling
    • 2
  • Vincent P. Vinciguerra
    • 6
  • Thomas Anderson
    • 7
  • Lisa Evans
    • 8
  • James Wade
    • 9
  • Alice P. Pentland
    • 1
  • Gary R. Morrow
    • 3
    • 4
  1. 1.Department of DermatologyUniversity of Rochester Medical CenterRochesterUSA
  2. 2.Department of Radiation OncologyUniversity of Rochester Medical CenterRochesterUSA
  3. 3.URCC NCORP Research BaseUniversity of Rochester Medical CenterRochesterUSA
  4. 4.Department of SurgeryUniversity of Rochester Medical CenterRochesterUSA
  5. 5.Department of AnesthesiologyUniversity of Rochester Medical CenterRochesterUSA
  6. 6.North Shore-LIJ Cancer InstituteNew Hyde ParkUSA
  7. 7.Columbus NCORPColumbusUSA
  8. 8.Southeast Clinical Oncology Research ConsortiumWinston-SalemUSA
  9. 9.Heartland NCORPDecaturUSA

Personalised recommendations